A high-throughput screening identifies microRNA inhibitors that influence neuronal maintenance and/or response to oxidative stress

dc.contributor.authorPallarès Albanell, Joan
dc.contributor.authorZomeño Abellán, M. Teresa
dc.contributor.authorEscaramís Babiano, Geòrgia
dc.contributor.authorPantano, Lorena
dc.contributor.authorSoriano, Aroa
dc.contributor.authorSegura, Miguel F.
dc.contributor.authorMartí Puig, Eulàlia
dc.date.accessioned2020-05-22T15:54:45Z
dc.date.available2020-05-22T15:54:45Z
dc.date.issued2019-09-06
dc.date.updated2020-05-22T15:54:45Z
dc.description.abstractSmall non-coding RNAs (sncRNAs), including microRNAs (miRNAs) are important post-transcriptional gene expression regulators relevant in physiological and pathological processes. Here, we combined a high-throughput functional screening (HTFS) platform with a library of antisense oligonucleotides (ASOs) to systematically identify sncRNAs that affect neuronal cell survival in basal conditions and in response to oxidative stress (OS), a major hallmark in neurodegenerative diseases. We considered hits commonly detected by two statistical methods in three biological replicates. Forty-seven ASOs targeting miRNAs (miRNA-ASOs) consistently decreased cell viability under basal conditions. A total of 60 miRNA-ASOs worsened cell viability impairment mediated by OS, with 36.6% commonly affecting cell viability under basal conditions. In addition, 40 miRNA-ASOs significantly protected neuronal cells from OS. In agreement with cell viability impairment, damaging miRNA-ASOs specifically induced increased free radical biogenesis. miRNAs targeted by the detrimental ASOs are enriched in the fraction of miRNAs downregulated by OS, suggesting that the miRNA expression pattern after OS contributes to neuronal damage. The present HTFS highlighted potentially druggable sncRNAs. However, future studies are needed to define the pathways by which the identified ASOs regulate cell survival and OS response and to explore the potential of translating the current findings into clinical applications.
dc.format.extent14 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec695572
dc.identifier.issn2162-2531
dc.identifier.pmid31302497
dc.identifier.urihttps://hdl.handle.net/2445/162069
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.omtn.2019.06.007
dc.relation.ispartofMolecular Therapy-Nucleic Acids, 2019, vol. 17, p. 374-387
dc.relation.urihttps://doi.org/10.1016/j.omtn.2019.06.007
dc.rightscc-by-nc-nd (c) Pallarès-Albanell, Joan et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.sourceArticles publicats en revistes (Biomedicina)
dc.subject.classificationOligonucleòtids
dc.subject.classificationMalalties neurodegeneratives
dc.subject.classificationCèl·lules
dc.subject.classificationOrigen de la vida
dc.subject.otherOligonucleotides
dc.subject.otherNeurodegenerative Diseases
dc.subject.otherCells
dc.subject.otherOrigin of life
dc.titleA high-throughput screening identifies microRNA inhibitors that influence neuronal maintenance and/or response to oxidative stress
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
695572.pdf
Mida:
876.81 KB
Format:
Adobe Portable Document Format